Hostname: page-component-586b7cd67f-dsjbd Total loading time: 0 Render date: 2024-11-27T13:49:08.856Z Has data issue: false hasContentIssue false
  • English
  • Français

Intrathecal Synthesis of Autoantibodies to Myelin Basic Protein in MultipleSclerosis

Published online by Cambridge University Press:  18 September 2015

Ingrid Catz  and
Kenneth G. Warren
Ingrid Catz*
Affiliation:
Departments of Laboratory Medicine and Medicine (Neurology), University of Alberta Hospital, Edmonton, Alberta
Kenneth G. Warren
Affiliation:
Departments of Laboratory Medicine and Medicine (Neurology), University of Alberta Hospital, Edmonton, Alberta
*
Department of Laboratory Medicine, WMC-4B4-30, University of Alberta Hospital, Edmonton, Alberta, Canada T6G 2G3
Rights & Permissions [Opens in a new window]

Abstract:

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

A solid phase radioimmunoassay was used to detect anti-myelin basic protein (MBP) antibodies in the CSF and serum of multiple sclerosis (MS) patients and controls. CSF and serum samples were assayed prior to acid hydrolysis in order to detect free anti-MBP as well as after acid hydrolysis to measure the total (free and bound) amount of antibody. An anti-MBP index controlling for serum levels as well as the degree of breakdown of the blood brain barrier was used to estimate intrathecal synthesis of anti-MBP. MS patients with acute exacerbations or chronically progressive disease have significantly elevated levels of both free and total CSF anti-MBP. The anti-MBP index is also significantly increased in MS patients with both forms of active disease. Anti-MBP antibodies are intrathecally produced in MS patients with active disease.

Type
Original Articles
Information
Canadian Journal of Neurological Sciences , Volume 13 , Issue 1 , February 1986 , pp. 21 - 24
Copyright
Copyright © Canadian Neurological Sciences Federation 1986

References

REFERENCES

1.Rivers, TM, Sprunt, DH, Berry, GP.Observations on attempts to produce acute disseminated encephalomyelitis in monkeys. J Exp Med 1933; 58: 39–53.CrossRefGoogle ScholarPubMed
2.Cohen, SR, Brooks, BR, Herndon, RM, McKhann, GM.A diagnostic index of active demyelination: Myelin basic protein in cerebrospinal fluid. Ann Neurol 1980; 8: 25–31.CrossRefGoogle ScholarPubMed
3.Whittaker, JN, Lisak, RP, Bashir, RMet al. Immunoreactive myelin basic protein in the cerebrospinal fluid in neurological diseases. Ann Neurol 1980; 7: 58–64.CrossRefGoogle Scholar
4.Warren, KG, Catz, I, McPherson, TA.CSF myelin basic protein levels in acute optic neuritis and multiple sclerosis. Can J Neurol Sci 1983; 10: 235–238.CrossRefGoogle ScholarPubMed
5.Rabat, EA, Glusman, M, and Knaub, V.Quantitative estimation of the albumin and gamma globulin in normal and pathologic cerebrospinal fluid by immunochemical methods. Ann J Med 1948; 4: 653–662.Google Scholar
6.Tourtellotte, WW.On cerebrospinal fluid IgG quotients in multiple sclerosis and other diseases. A review and new formula to estimate the amount of IgG synthesized per day by the central nervous system. J Neurol Sci 1970; 10: 279–304.CrossRefGoogle Scholar
7.Link, H, Tibbling, G.Principles of albumin and IgG analyses in neurological disorders. II. Evaluation of IgG synthesis within the central nervous system in multiple sclerosis. Scand J Clin Lab Invest 1977; 37: 397–401.CrossRefGoogle Scholar
8.Tourtellotte, WW, Ma, Bl.Multiple sclerosis: The blood brain barrier and the measurement of de novo central nervous system IgG synthesis. Neurology 1978; 28: 76–83.CrossRefGoogle ScholarPubMed
9.Warren, KG, Catz, I.An investigation of the relationship between cerebrospinal fluid myelin basic protein levels and IgG measurements in multiple sclerosis patients. Ann Neurol 1985; 17:475–480.CrossRefGoogle Scholar
10.Delmotte, P.Gel isoelectric focusing of CSF proteins: A potential diagnostic test. Z Klin Chem Biochem 1971; 9: 334–336.Google Scholar
11.Link, H.Oligoclonal IgG in MS brain. J Neurosci 1972; 16: 103–114.Google Scholar
12.Johnson, KP, Nelson, BJ.Multiple sclerosis: diagnostic usefulness of cerebrospinal fluid. Ann Neurol 1977; 2: 425–431.CrossRefGoogle ScholarPubMed
13.Gilden, D, Tachovsky, T.Immunoglobulin elution from multiple sclerosis brain. J Neurosci Methods 1979; 1: 133–142.CrossRefGoogle ScholarPubMed
14.Mattson, DH, Roos, RP, Arnason, BJW.IEF of IgG eluted from MS and SSPE brains. Nature 1980; 287: 335–337.CrossRefGoogle Scholar
15.Mattson, DH, Roos, RP, Arnason, BJW.Oligoclonal IgG in multiple sclerosis and subacute sclerosing panencephalitis. J Neuroimmunol 1982; 2: 261–276.CrossRefGoogle ScholarPubMed
16.Dasgupta, MK, Catz, I, Warren, KG, McPherson, TA, Dossetor, JB, Carnegie, PR.Myelin basic protein: A component of circulating immune complexes in multiple sclerosis. Can J Neurol Sci 1983; 10: 239–423.CrossRefGoogle ScholarPubMed
17.Chou, CHH, Tourtellotte, WW, Hicks, JT, Sato, H, Boone, EJ, Potvin, AR.Failure to detect antibodies to myelin basic protein or peptic fragments of myelin basic protein in CSF of patients with MS. Neurology 1983; 33: 24–28.CrossRefGoogle ScholarPubMed
18.Hunter, WM, Greenwood, FC.Preparation of I131 human growth hormone of high specific activity. Nature 1962; 195: 495–496.CrossRefGoogle Scholar
19.Schumacher, GA, Beebe, G, Kiebler, REet al. Problems of experimental trials of therapy in multiple sclerosis. Ann NY Acad Sci 1965; 122: 552–568.CrossRefGoogle ScholarPubMed
20.Panitch, HS, Hooper, CJ, Johnson, KP.CSF antibody to myelin basic protein. Measurement in patients with multiple sclerosis and subacute sclerosing panencephalitis. Arch Neurol 1980; 37:206–209.CrossRefGoogle ScholarPubMed
21.Ruutianen, J, Arnadottir, T, Molnar, Get al.Myelin basic protein antibodies in the serum and CSF of multiple sclerosis and subacute sclerosing panencephalitis. (1981). Acta Neurol Scand 1981; 64: 196–206.CrossRefGoogle Scholar
22.Wajgt, A, Gorny, M.Antibodies to myelin basic protein and to myelin-associated glycoprotein in multiple sclerosis. Evidence of intrathecal production of antibodies. Acta Neurol Scand 1983; 68: 337–343.CrossRefGoogle ScholarPubMed
23.Abramsky, O, Lisak, RP, Silberberg, DH, Pleasure, DE.Antibodies to oligodendria in patients with multiple sclerosis. N Eng J Med 1977; 297: 1207–1211.CrossRefGoogle Scholar
24.Gorny, MK, Wroblewska, Z, Pleasure, Det al. CSF antibodies to myelin basic protein and oligodendrocytes in multiple sclerosis and other neurological diseases. Acta Neurol Scand 1983; 67: 338–347.CrossRefGoogle ScholarPubMed
25.Adams, JM, Imagawa, DT.Measles antibodies in multiple sclerosis. Proc Soc Exp Biol Med III 1962; 562–566.CrossRefGoogle ScholarPubMed
26.Rorby, E, Link, H, Alsson, JEet al. Comparison of antibodies against different viruses in cerebrospinal fluid and serum samples from patients with multiple sclerosis. Infect Immunity 1974; 10:688–694.Google Scholar
27.Baird, LG, Tachovsky, TC, Sandberg-Wolheim, MMetal. Identification of a unique idiotype in cerebrospinal fluid and serum of a patient with multiple sclerosis. J Immunol 1980; 124: 2324–2328.CrossRefGoogle ScholarPubMed
28.Nagelkerken, LM, Aalberse, NC, Van Waebeck, HK, Out, TA.Preparation of antisera directed against the idiotype(s) of IgG from the cerebrospinal fluid of patients with multiple sclerosis. J Immunol 1980; 125: 384–389.CrossRefGoogle Scholar